Argenx Se ARGX
NASDAQ ARGX
$929.07 +34.30 (+3.83%)
As of: Nov 6, 2026 · 3:59 PM EST

Argenx Se (ARGX) Price to Earnings (2017 - 2026)

Updated

Argenx Se's Price to Earnings was 31.62 in Q3 2026, up 8.1% from 29.24 a year earlier but down 5.6% from the prior quarter.

Analysis

Argenx Se (ARGX) Price to Earnings (2017 - 2026) Analysis & Trends

For FY2025, Price to Earnings at Argenx Se came in at 40.28, down 10.2% from FY2024.

  • In earlier years, Price to Earnings was 44.86 in FY2024.
  • Quarterly Price to Earnings has moved between 26.17 (Q2 2025) and 44.86 (Q4 2024) over five years.
  • Compared with a year earlier, Price to Earnings was higher in two of the last four quarters, with growth averaging 3.9%.
  • Per Business Quant data, ARGX's Price to Earnings in the three quarters before Q3 2026 was 33.48 (Q2 2026), 30.36 (Q1 2026) and 40.30 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Argenx Se 56.96 Bn 56.96 Bn 1.56 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 31.62
Jun 30, 2026 33.48
Mar 31, 2026 30.36
Dec 31, 2025 40.30
Sep 30, 2025 29.24
Jun 30, 2025 26.17
Mar 31, 2025 33.81
Dec 31, 2024 44.86
Sep 30, 2017 42.34
API Access

Argenx Se Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ARGX&period=max&api_key=YOUR_API_KEY